| Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis N Singh, A Gurav, S Sivaprakasam, E Brady, R Padia, H Shi, ... Immunity 40 (1), 128-139, 2014 | 2006 | 2014 |
| DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis R Pathania, S Ramachandran, S Elangovan, R Padia, P Yang, S Cinghu, ... Nature communications 6 (1), 6910, 2015 | 251 | 2015 |
| Extracellular signal–regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression H Chen, G Zhu, Y Li, RN Padia, Z Dong, ZK Pan, K Liu, S Huang Cancer research 69 (24), 9228-9235, 2009 | 209 | 2009 |
| The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival S Elangovan, R Pathania, S Ramachandran, S Ananth, RN Padia, L Lan, ... Cancer research 74 (4), 1166-1178, 2014 | 123 | 2014 |
| Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration S Su, Y Li, Y Luo, Y Sheng, Y Su, RN Padia, ZK Pan, Z Dong, S Huang Oncogene 28 (34), 3047-3057, 2009 | 114 | 2009 |
| Signaling by p38 MAPK stimulates nuclear localization of the microprocessor component p68 for processing of selected primary microRNAs S Hong, H Noh, H Chen, R Padia, ZK Pan, SB Su, Q Jing, HF Ding, ... Science signaling 6 (266), ra16-ra16, 2013 | 67 | 2013 |
| COP1 and GSK3β cooperate to promote c-Jun degradation and inhibit breast cancer cell tumorigenesis J Shao, Y Teng, R Padia, S Hong, H Noh, X Xie, JS Mumm, Z Dong, ... Neoplasia 15 (9), 1075-IN11, 2013 | 63 | 2013 |
| Molecular mechanism of SLC5A8 inactivation in breast cancer S Elangovan, R Pathania, S Ramachandran, S Ananth, RN Padia, ... Molecular and cellular biology 33 (19), 3920-3935, 2013 | 35 | 2013 |
| Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2’, 4’-Tetrahydroxychalcone C Chen, AK Shenoy, R Padia, D Fang, Q Jing, P Yang, SB Su, S Huang Journal of Experimental & Clinical Cancer Research 37, 1-14, 2018 | 32 | 2018 |
| Addiction to protein kinase Cɩ due to PRKCI gene amplification can be exploited for an aptamer-based targeted therapy in ovarian cancer H Rehmani, Y Li, T Li, R Padia, O Calbay, L Jin, H Chen, S Huang Signal transduction and targeted therapy 5 (1), 140, 2020 | 26 | 2020 |
| Signaling of MK2 sustains robust AP1 activity for triple negative breast cancer tumorigenesis through direct phosphorylation of JAB1 H Chen, R Padia, T Li, Y Li, B Li, L Jin, S Huang NPJ Breast Cancer 7 (1), 91, 2021 | 9 | 2021 |
| Attenuated miR-203b-3p is critical for ovarian cancer progression and aptamer/miR-203b-3p chimera can be explored as a therapeutic T Li, Y Li, H Rehmani, J Guo, R Padia, O Calbay, Z Ding, Y Jiang, L Jin, ... Advances in Cancer Biology-Metastasis 4, 100031, 2022 | 6 | 2022 |
| HOXC8 epigenetically controls caspse-1 expression and pyroptosis in lung cancer cells L Sun, R Padia, O Calbay, C Chi, M Akter, L Jin, S Huang Cancer Research 84 (6_Supplement), 6004-6004, 2024 | | 2024 |
| ASC/inflammasome-independent pyroptosis in ovarian cancer cells through translational augmentation of caspase-1 O Calbay, R Padia, M Akter, L Sun, B Li, N Qian, J Guo, Z Fu, L Jin, ... Iscience 26 (12), 2023 | | 2023 |
| SLC5A8: A strategic target for advanced metastatic breast cancer S Ramachandran, R Pathania, RN Padia, S Elangovan, ... Cancer Research 74 (19_Supplement), 2461-2461, 2014 | | 2014 |
| Molecular Mechanism of SLC5A8 VG Prasad, M Thangaraju, TB Schoenlein, SB Smith, D Puttur, ... | | 2013 |
| Advances in Cancer Biology-Metastasis T Li, Y Li, H Rehmani, J Guo, R Padia, O Calbay, Z Ding, Y Jiang, L Jin, ... | | |
